Astrocyte Pharmaceuticals

About:

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.

Website: https://www.astrocytepharma.com/

Twitter/X: astrocytepharma

Top Investors: National Institutes of Health, National Institute on Aging, Small Business Innovation Research, Alzheimer's Drug Discovery Foundation, DeepWork Capital

Description:

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke, TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.

Total Funding Amount:

$37.2M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)astrocytepharma.com

Founders:

James Lechleiter, William Korinek

Number of Employees:

1-10

Last Funding Date:

2023-08-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai